Literature DB >> 11001602

Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

D I Kaufer1, J L Cummings, P Ketchel, V Smith, A MacMillan, T Shelley, O L Lopez, S T DeKosky.   

Abstract

The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for evaluating psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), intended for use in routine clinical practice, and cross-validated it with the NPI in 60 Alzheimer's patients. Test-retest reliability of the NPI-Q was acceptable. The prevalence of analogous symptoms reported on the NPI and NPI-Q differed on average by 5%; moderate or severe symptom ratings differed by less than 2%. The NPI-Q provides a brief, reliable, informant-based assessment of neuropsychiatric symptoms and associated caregiver distress that may be suitable for use in general clinical practice.

Entities:  

Mesh：

Year:  2000        PMID： 11001602     DOI： 10.1176/jnp.12.2.233

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  553 in total

1.  Neurosarcoidosis and the complexity in its differential diagnoses: a review.

Authors:  David R Spiegel; Kristyn Morris; Ubha Rayamajhi
Journal:  Innov Clin Neurosci       Date:  2012-04

2.  Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.

Authors:  Mary Sano; Carolyn W Zhu; Hillel Grossman; Corbett Schimming
Journal:  J Am Geriatr Soc       Date:  2017-08-03       Impact factor: 5.562

3.  Amyloid imaging of Lewy body-associated disorders.

Authors:  Erin R Foster; Meghan C Campbell; Michelle A Burack; Johanna Hartlein; Hubert P Flores; Nigel J Cairns; Tamara Hershey; Joel S Perlmutter
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

4.  The University of California at Los Angeles Alzheimer's and Dementia Care program for comprehensive, coordinated, patient-centered care: preliminary data.

Authors:  David B Reuben; Leslie C Evertson; Neil S Wenger; Katherine Serrano; Joshua Chodosh; Linda Ercoli; Zaldy S Tan
Journal:  J Am Geriatr Soc       Date:  2013-12-03       Impact factor: 5.562

5.  Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.

Authors:  Sarah E Monsell; Lilah M Besser; Katherine B Heller; Harvey Checkoway; Irene Litvan; Walter A Kukull
Journal:  Parkinsonism Relat Disord       Date:  2014-02-13       Impact factor: 4.891

6.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Testing Tele-Savvy: Protocol for a randomized controlled trial.

Authors:  Mariya A Kovaleva; Elizabeth Bilsborough; Patricia C Griffiths; Joe Nocera; Melinda Higgins; Fayron Epps; Katie Kilgore; Allison Lindauer; Darby Morhardt; Raj C Shah; Kenneth Hepburn
Journal:  Res Nurs Health       Date:  2018-02-05       Impact factor: 2.228

8.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

9.  Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Authors:  Mark S Cary; Jonathan D Rubright; Joshua D Grill; Jason Karlawish
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

10.  Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Maria Jose Catalan; Jose Antonio Molina-Arjona; Pablo Mir; Esther Cubo; Jose Matias Arbelo; Pablo Martinez-Martin
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.